BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15250039)

  • 1. Challenges and strategies: the immune responses in gene therapy.
    Zhou HS; Liu DP; Liang CC
    Med Res Rev; 2004 Nov; 24(6):748-61. PubMed ID: 15250039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How not to be seen: immune-evasion strategies in gene therapy.
    Zaldumbide A; Hoeben RC
    Gene Ther; 2008 Feb; 15(4):239-46. PubMed ID: 18046427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune response induced by gene delivery vectors.
    Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
    Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivector and antitransgene host responses in gene therapy.
    Hackett NR; Kaminsky SM; Sondhi D; Crystal RG
    Curr Opin Mol Ther; 2000 Aug; 2(4):376-82. PubMed ID: 11249767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
    Jooss K; Chirmule N
    Gene Ther; 2003 Jun; 10(11):955-63. PubMed ID: 12756416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards safe, non-viral therapeutic gene expression in humans.
    Glover DJ; Lipps HJ; Jans DA
    Nat Rev Genet; 2005 Apr; 6(4):299-310. PubMed ID: 15761468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and genetic therapies for haemophilia.
    Lillicrap D; VandenDriessche T; High K
    Haemophilia; 2006 Jul; 12 Suppl 3():36-41. PubMed ID: 16683995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.
    Bessis N; GarciaCozar FJ; Boissier MC
    Gene Ther; 2004 Oct; 11 Suppl 1():S10-7. PubMed ID: 15454952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress and challenges in viral vector-mediated gene transfer to the brain.
    Lowenstein PR; Castro MG
    Curr Opin Mol Ther; 2002 Aug; 4(4):359-71. PubMed ID: 12222874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and application of alphaviruses in gene therapy.
    Lundstrom K
    Gene Ther; 2005 Oct; 12 Suppl 1():S92-7. PubMed ID: 16231060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-viral ocular gene therapy: potential ocular therapeutic avenues.
    Bloquel C; Bourges JL; Touchard E; Berdugo M; BenEzra D; Behar-Cohen F
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1224-42. PubMed ID: 17095114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy with poxvirus vectors.
    Moroziewicz D; Kaufman HL
    Curr Opin Mol Ther; 2005 Aug; 7(4):317-25. PubMed ID: 16121697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-viral amplification systems for gene transfer: vectors based on alphaviruses.
    Smerdou C; Liljeström P
    Curr Opin Mol Ther; 1999 Apr; 1(2):244-51. PubMed ID: 11715947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current prospects for gene therapy of cystic fibrosis.
    Ziady AG; Davis PB
    Curr Opin Pharmacol; 2006 Oct; 6(5):515-21. PubMed ID: 16890018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting strategies in cancer gene therapy.
    Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for cystic fibrosis lung disease: current status and future perspectives.
    Rosenecker J; Huth S; Rudolph C
    Curr Opin Mol Ther; 2006 Oct; 8(5):439-45. PubMed ID: 17078386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer.
    Kuroda H; Kutner RH; Bazan NG; Reiser J
    J Gene Med; 2008 Nov; 10(11):1163-75. PubMed ID: 18773500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vectors and delivery systems in gene therapy.
    Gardlík R; Pálffy R; Hodosy J; Lukács J; Turna J; Celec P
    Med Sci Monit; 2005 Apr; 11(4):RA110-21. PubMed ID: 15795707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters.
    Weeratna RD; Wu T; Efler SM; Zhang L; Davis HL
    Gene Ther; 2001 Dec; 8(24):1872-8. PubMed ID: 11821941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.